Literature DB >> 19347024

Diagnosis and management of the neurological complications of falciparum malaria.

Saroj K Mishra1, Charles R J C Newton.   

Abstract

Malaria is a major public health problem in the developing world owing to its high rates of morbidity and mortality. Of all the malarial parasites that infect humans, Plasmodium falciparum is most commonly associated with neurological complications, which manifest as agitation, psychosis, seizures, impaired consciousness and coma (cerebral malaria). Cerebral malaria is the most severe neurological complication; the condition is associated with mortality of 15-20%, and a substantial proportion of individuals with this condition develop neurocognitive sequelae. In this Review, we describe the various neurological complications encountered in malaria, discuss the underlying pathogenesis, and outline current management strategies for these complications. Furthermore, we discuss the role of adjunctive therapies in improving outcome.

Entities:  

Mesh:

Year:  2009        PMID: 19347024      PMCID: PMC2859240          DOI: 10.1038/nrneurol.2009.23

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  96 in total

1.  Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: a meta-analysis.

Authors:  Mark S Riddle; Jeffrey L Jackson; John W Sanders; David L Blazes
Journal:  Clin Infect Dis       Date:  2002-04-03       Impact factor: 9.079

2.  Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study.

Authors:  J Crawley; C Waruiru; S Mithwani; I Mwangi; W Watkins; D Ouma; P Winstanley; T Peto; K Marsh
Journal:  Lancet       Date:  2000-02-26       Impact factor: 79.321

Review 3.  Cerebral malaria.

Authors:  G Turner
Journal:  Brain Pathol       Date:  1997-01       Impact factor: 6.508

4.  Post-malarial cerebellar ataxia in adult Sudanese patients.

Authors:  M N Abdulla; T E Sokrab; Z A Zaidan; H E Siddig; M E Ali
Journal:  East Afr Med J       Date:  1997-09

Review 5.  Mannitol and other osmotic diuretics as adjuncts for treating cerebral malaria.

Authors:  C A N Okoromah; B B Afolabi
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

6.  Post-malaria neurological syndrome.

Authors:  T H Nguyen; N P Day; V C Ly; D Waller; N T Mai; D B Bethell; T H Tran; N J White
Journal:  Lancet       Date:  1996-10-05       Impact factor: 79.321

7.  Hypoglycaemia and counterregulatory hormone responses in severe falciparum malaria: treatment with Sandostatin.

Authors:  R E Phillips; S Looareesuwan; M E Molyneux; C Hatz; D A Warrell
Journal:  Q J Med       Date:  1993-04

8.  Malaria and bacterial sepsis: similar mechanisms of endothelial apoptosis and its prevention in vitro.

Authors:  Christoph J Hemmer; Anna Vogt; Marcus Unverricht; Robert Krause; Matthias Lademann; Emil C Reisinger
Journal:  Crit Care Med       Date:  2008-09       Impact factor: 7.598

9.  Pharmacokinetics and clinical effect of phenobarbital in children with severe falciparum malaria and convulsions.

Authors:  Gilbert O Kokwaro; Bernhards R Ogutu; Simon N Muchohi; Godfrey O Otieno; Charles R J C Newton
Journal:  Br J Clin Pharmacol       Date:  2003-10       Impact factor: 4.335

10.  Mannitol as adjunct therapy for childhood cerebral malaria in Uganda: a randomized clinical trial.

Authors:  Beatrice Namutangula; Grace Ndeezi; Justus S Byarugaba; James K Tumwine
Journal:  Malar J       Date:  2007-10-24       Impact factor: 2.979

View more
  57 in total

1.  MRI demonstrates glutamine antagonist-mediated reversal of cerebral malaria pathology in mice.

Authors:  Brittany A Riggle; Sanhita Sinharay; William Schreiber-Stainthorp; Jeeva P Munasinghe; Dragan Maric; Eva Prchalova; Barbara S Slusher; Jonathan D Powell; Louis H Miller; Susan K Pierce; Dima A Hammoud
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-04       Impact factor: 11.205

2.  Perforin Expression by CD8 T Cells Is Sufficient To Cause Fatal Brain Edema during Experimental Cerebral Malaria.

Authors:  Matthew A Huggins; Holly L Johnson; Fang Jin; Aurelie N Songo; Lisa M Hanson; Stephanie J LaFrance; Noah S Butler; John T Harty; Aaron J Johnson
Journal:  Infect Immun       Date:  2017-04-21       Impact factor: 3.441

3.  Evaluation of a TaqMan Array Card for Detection of Central Nervous System Infections.

Authors:  Clayton O Onyango; Vladimir Loparev; Shirley Lidechi; Vinod Bhullar; D Scott Schmid; Kay Radford; Michael K Lo; Paul Rota; Barbara W Johnson; Jorge Munoz; Martina Oneko; Deron Burton; Carolyn M Black; John Neatherlin; Joel M Montgomery; Barry Fields
Journal:  J Clin Microbiol       Date:  2017-04-12       Impact factor: 5.948

Review 4.  Mannitol and other osmotic diuretics as adjuncts for treating cerebral malaria.

Authors:  Christy An Okoromah; Bosede B Afolabi; Emma Cb Wall
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

5.  Case Report: A Case of Severe Cerebral Malaria Managed with Therapeutic Hypothermia and Other Modalities for Brain Edema.

Authors:  AbdAllah Gad; Sajjad Ali; Talal Zahoor; Nick Azarov
Journal:  Am J Trop Med Hyg       Date:  2018-02-01       Impact factor: 2.345

6.  Infectious disease: Pathogenesis of cerebral malaria-a step forward.

Authors:  Sudhanshu S Pati; Saroj K Mishra
Journal:  Nat Rev Neurol       Date:  2012-07-24       Impact factor: 42.937

7.  VEGF and LPS synergistically silence inflammatory response to Plasmodium berghei infection and protect against cerebral malaria.

Authors:  Miriam Canavese; Tania Dottorini; Andrea Crisanti
Journal:  Pathog Glob Health       Date:  2015-09-21       Impact factor: 2.894

8.  Metabolic acidosis induced by Plasmodium falciparum intraerythrocytic stages alters blood-brain barrier integrity.

Authors:  Sergine Zougbédé; Florence Miller; Philippe Ravassard; Angelita Rebollo; Liliane Cicéron; Pierre-Olivier Couraud; Dominique Mazier; Alicia Moreno
Journal:  J Cereb Blood Flow Metab       Date:  2010-08-04       Impact factor: 6.200

9.  Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.

Authors:  Sylvie Briquet; Nadou Lawson-Hogban; Bertrand Boisson; Miguel P Soares; Roger Péronet; Leanna Smith; Robert Ménard; Michel Huerre; Salah Mécheri; Catherine Vaquero
Journal:  Infect Immun       Date:  2015-04-27       Impact factor: 3.441

Review 10.  Sequestration and tissue accumulation of human malaria parasites: can we learn anything from rodent models of malaria?

Authors:  Blandine Franke-Fayard; Jannik Fonager; Anneke Braks; Shahid M Khan; Chris J Janse
Journal:  PLoS Pathog       Date:  2010-09-30       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.